AAAAAA

   
Results: 1-13 |
Results: 13
FUNCTIONAL-STUDIES OF 12 MUTANT V-2 VASOPRESSIN RECEPTORS RELATED TO NEPHROGENIC DIABETES-INSIPIDUS - MOLECULAR-BASIS OF A MILD CLINICAL PHENOTYPE
Authors: ALA Y MORIN D MOUILLAC B SABATIER N VARGAS R COTTE N DECHAUX M ANTIGNAC C ARTHUS MF LONERGAN M TURNER MS BALESTRE MN ALONSO G HIBERT M BARBERIS C HENDY GN BICHET DG JARD S
Citation: Y. Ala et al., FUNCTIONAL-STUDIES OF 12 MUTANT V-2 VASOPRESSIN RECEPTORS RELATED TO NEPHROGENIC DIABETES-INSIPIDUS - MOLECULAR-BASIS OF A MILD CLINICAL PHENOTYPE, Journal of the American Society of Nephrology, 9(10), 1998, pp. 1861-1872
FUNCTIONAL-STUDY OF V2 RECEPTOR GENE-MUTA TIONS RESPONSIBLE FOR CONGENITAL NEPHROGENIC DIABETES-INSIPIDUS
Authors: MORIN D ALA Y VARGAS R SABATIER N ANTIGNAC C DECHAUX M LOIRAT C BROYER M DUMAS R BICHET D JARD S BARBERIS C
Citation: D. Morin et al., FUNCTIONAL-STUDY OF V2 RECEPTOR GENE-MUTA TIONS RESPONSIBLE FOR CONGENITAL NEPHROGENIC DIABETES-INSIPIDUS, Archives de pediatrie, 4, 1997, pp. 193-194
MAPPING PEPTIDE-BINDING DOMAINS OF THE HUMAN V1A VASOPRESSIN RECEPTORWITH A PHOTOACTIVATABLE LINEAR PEPTIDE ANTAGONIST
Authors: PHALIPOU S COTTE N CARNAZZI E SEYER R MAHE E JARD S BARBERIS C MOUILLAC B
Citation: S. Phalipou et al., MAPPING PEPTIDE-BINDING DOMAINS OF THE HUMAN V1A VASOPRESSIN RECEPTORWITH A PHOTOACTIVATABLE LINEAR PEPTIDE ANTAGONIST, The Journal of biological chemistry, 272(42), 1997, pp. 26536-26544
PROPERTIES OF A NEW RADIOIODINATED ANTAGONIST FOR HUMAN VASOPRESSIN V-2 AND V-1A RECEPTORS
Authors: ALA Y MORIN D MAHE E COTTE N MOUILLAC B JARD S BARBERIS C TRIBOLLET E DREIFUSS JJ SAWYER WH WO NC CHAN WY KOLODZIEJCZYK AS CHENG LL MANNING M
Citation: Y. Ala et al., PROPERTIES OF A NEW RADIOIODINATED ANTAGONIST FOR HUMAN VASOPRESSIN V-2 AND V-1A RECEPTORS, European journal of pharmacology, 331(2-3), 1997, pp. 285-293
CHARACTERIZATION OF SR 121463A, A HIGHLY POTENT AND SELECTIVE, ORALLY-ACTIVE VASOPRESSIN V-2 RECEPTOR ANTAGONIST
Authors: SERRADEILLEGAL C LACOUR C VALETTE G GARCIA G FOULON L GALINDO G BANKIR L POUZET B GUILLON G BARBERIS C CHICOT D JARD S VILAIN P GARCIA C MARTY E RAUFASTE D BROSSARD G NISATO D MAFFRAND JP LEFUR G
Citation: C. Serradeillegal et al., CHARACTERIZATION OF SR 121463A, A HIGHLY POTENT AND SELECTIVE, ORALLY-ACTIVE VASOPRESSIN V-2 RECEPTOR ANTAGONIST, The Journal of clinical investigation, 98(12), 1996, pp. 2729-2738
2 AROMATIC RESIDUES REGULATE THE RESPONSE OF THE HUMAN OXYTOCIN RECEPTOR TO THE PARTIAL AGONIST ARGININE-VASOPRESSIN
Authors: CHINI B MOUILLAC B BALESTRE MN TRUMPPKALLMEYER S HOFLACK J HIBERT M ANDRIOLO M PUPIER S JARD S BARBERIS C
Citation: B. Chini et al., 2 AROMATIC RESIDUES REGULATE THE RESPONSE OF THE HUMAN OXYTOCIN RECEPTOR TO THE PARTIAL AGONIST ARGININE-VASOPRESSIN, FEBS letters, 397(2-3), 1996, pp. 201-206
TYR115 IS THE KEY RESIDUE FOR DETERMINING AGONIST SELECTIVITY IN THE V1A VASOPRESSIN RECEPTOR
Authors: CHINI B MOUILLAC B ALA Y BALESTRE MN TRUMPPKALLMEYER S HOFLACK J ELANDS J HIBERT M MANNING M JARD S BARBERIS C
Citation: B. Chini et al., TYR115 IS THE KEY RESIDUE FOR DETERMINING AGONIST SELECTIVITY IN THE V1A VASOPRESSIN RECEPTOR, EMBO journal, 14(10), 1995, pp. 2176-2182
3D MODELS OF HORMONE RECEPTORS - EXPERIMENTAL VALIDATION
Authors: HIBERT M HOFLACK J TRUMPPKALLMEYER S PAQUET JL LEPPIK R BARBERIS C MOUILLAC B CHINI B JARD S
Citation: M. Hibert et al., 3D MODELS OF HORMONE RECEPTORS - EXPERIMENTAL VALIDATION, European journal of medicinal chemistry, 30, 1995, pp. 189-199
CHARACTERIZATION OF A NOVEL, LINEAR RADIOIODINATED VASOPRESSIN ANTAGONIST - AN EXCELLENT RADIOLIGAND FOR VASOPRESSIN V-1A RECEPTORS
Authors: BARBERIS C BALESTRE MN JARD S TRIBOLLET E ARSENIJEVIC Y DREIFUSS JJ BANKOWSKI K MANNING M CHAN WY SCHLOSSER SS HOLSBOER F ELANDS J
Citation: C. Barberis et al., CHARACTERIZATION OF A NOVEL, LINEAR RADIOIODINATED VASOPRESSIN ANTAGONIST - AN EXCELLENT RADIOLIGAND FOR VASOPRESSIN V-1A RECEPTORS, Neuroendocrinology, 62(2), 1995, pp. 135-146
CLOSE ASSOCIATION OF THE ALPHA-SUBUNITS OF G(Q) AND G(11) G-PROTEINS WITH ACTIN-FILAMENTS IN WRK(1) CELLS - RELATION TO G PROTEIN-MEDIATED PHOSPHOLIPASE-C ACTIVATION
Authors: IBARRONDO J JOUBERT D DUFOUR MN COHENSOLAL A HOMBURGER V JARD S GUILLON G
Citation: J. Ibarrondo et al., CLOSE ASSOCIATION OF THE ALPHA-SUBUNITS OF G(Q) AND G(11) G-PROTEINS WITH ACTIN-FILAMENTS IN WRK(1) CELLS - RELATION TO G PROTEIN-MEDIATED PHOSPHOLIPASE-C ACTIVATION, Proceedings of the National Academy of Sciences of the United Statesof America, 92(18), 1995, pp. 8413-8417
THE BINDING-SITE OF NEUROPEPTIDE VASOPRESSIN V1A RECEPTOR - EVIDENCE FOR A MAJOR LOCALIZATION WITHIN TRANSMEMBRANE REGIONS
Authors: MOUILLAC B CHINI B BALESTRE MN ELANDS J TRUMPPKALLMEYER S HOFLACK J HIBERT M JARD S BARBERIS C
Citation: B. Mouillac et al., THE BINDING-SITE OF NEUROPEPTIDE VASOPRESSIN V1A RECEPTOR - EVIDENCE FOR A MAJOR LOCALIZATION WITHIN TRANSMEMBRANE REGIONS, The Journal of biological chemistry, 270(43), 1995, pp. 25771-25777
BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIES OF SR-49059, A NEW, POTENT, NONPEPTIDE ANTAGONIST OF RAT AND HUMAN VASOPRESSIN V1A RECEPTORS
Authors: SERRADEILLEGAL C WAGNON J GARCIA C LACOUR C GUIRAUDOU P CHRISTOPHE B VILLANOVA G NISATO D MAFFRAND JP LEFUR G GUILLON G CANTAU B BARBERIS C TRUEBA M ALA Y JARD S
Citation: C. Serradeillegal et al., BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIES OF SR-49059, A NEW, POTENT, NONPEPTIDE ANTAGONIST OF RAT AND HUMAN VASOPRESSIN V1A RECEPTORS, The Journal of clinical investigation, 92(1), 1993, pp. 224-231
LOCALIZATION AND CHARACTERIZATION OF VASOPRESSIN BINDING-SITES IN THERAT-BRAIN USING AN IODINATED LINEAR AVP ANTAGONIST
Authors: JOHNSON AE AUDIGIER S ROSSI F JARD S TRIBOLLET E BARBERIS C
Citation: Ae. Johnson et al., LOCALIZATION AND CHARACTERIZATION OF VASOPRESSIN BINDING-SITES IN THERAT-BRAIN USING AN IODINATED LINEAR AVP ANTAGONIST, Brain research, 622(1-2), 1993, pp. 9-16
Risultati: 1-13 |